ArticleVaccines2024

Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries.

Mateusz Hasso-Agopsowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.